Eli Lillys recently acquired manufacturing facility in Pleasant Prairie, WI, which its expanding with a $3 billion investment (Kyle LaHucik for Endpoints News) Lilly continues to expand its empire of GLP-1 factories with new $3B buildout PLEASANT PRAIRIE, WI A four-minute drive north of the Illinois-Wisconsin border in Americas Dairyland, Eli Lilly is staking one of its largest-ever manufacturing bets to Sign up to read this article for free
Neuroinflammation 10, 142
doi:10.1056/NEJMoa072761 4
Understanding the relationship between semaglutide therapy and neurological symptoms helps patients and clinicians distinguish medication effects from disease-related complications
doi: 10.1155/2016/3094642 34 MirmiraRGSimsEKSyedFEvans-MolinaC
In animal models, semaglutide reduces food intake and body weight by activating Adcyap1-expressing neurons in the dorsal vagal complex, a key integrator of gutbrain signals that induce a reduction in food intake via both homeostatic and hedonic pathways [78]